切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 618 -621. doi: 10.3877/cma.j.issn.2095-3232.2021.06.018

临床研究

原发性肝平滑肌肉瘤诊断与治疗
武洋1, 苗润晨1, 张兴1, 张月浪2, 马小华1, 刘昌1,()   
  1. 1. 710061 西安交通大学第一附属医院肝胆外科
    2. 710061 西安交通大学第一附属医院影像科
  • 收稿日期:2021-08-24 出版日期:2021-09-23
  • 通信作者: 刘昌

Diagnosis and treatments of primary hepatic leiomyosarcoma

Yang Wu1, Runchen Miao1, Xing Zhang1, Yuelang Zhang2, Xiaohua Ma1, Chang Liu1,()   

  1. 1. Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
    2. Department of Imaging, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
  • Received:2021-08-24 Published:2021-09-23
  • Corresponding author: Chang Liu
引用本文:

武洋, 苗润晨, 张兴, 张月浪, 马小华, 刘昌. 原发性肝平滑肌肉瘤诊断与治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 618-621.

Yang Wu, Runchen Miao, Xing Zhang, Yuelang Zhang, Xiaohua Ma, Chang Liu. Diagnosis and treatments of primary hepatic leiomyosarcoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(06): 618-621.

目的

探讨原发性肝平滑肌肉瘤的诊治方法。

方法

回顾性分析2017年10月在西安交通大学第一附属医院诊治的1例原发性肝平滑肌肉瘤患者临床资料。患者女,49岁,因"超声检查发现肝占位性病变"入院。超声检查示肝脏尾叶低回声区。腹部CT检查示肝右叶及尾状叶可见多发结节状及团块状低密度影。肝穿刺活检、免疫组化染色确诊原发性肝平滑肌肉瘤。治疗方案为TACE联合化疗。

结果

患者于2017年12月14日行TACE治疗,术后给予6个疗程的辅助化疗(吉西他滨+多西他赛)。2019年4月16日复查发现病变较前略扩大,化疗方案改为吉西他滨+白蛋白结合型紫杉醇,化疗3个周期。2020年5月20日复查提示病灶明显增大,再次行TACE治疗,术后患者恢复良好。截至2020年7月1日,患者生存质量良好,随访未见肿瘤复发。检索2000~2020年Pubmed共收录15例成年原发性肝平滑肌肉瘤患者,其中男6例,女9例;年龄25~77岁,中位年龄54岁。初发症状多表现为腹痛伴不适,肿瘤多发于右叶。实验室检查和影像学缺乏特异性表现。病理学检查示梭形组织细胞聚集呈束状排列;免疫组化染色示组织细胞SMA、desmin、vimentin阳性,S-100、细胞角蛋白阴性。手术切除9例,化疗2例,其中1例手术后联合化疗,肝移植术1例,TACE 2例,保守治疗2例。随访3~82个月,失访2例,死亡6例,存活7例。

结论

原发性肝平滑肌肉瘤是一种罕见疾病,病理学检查是确诊的唯一有效方式,手术切除可获得较好的疗效。

Objective

To investigate the diagnosis and treatments of primary hepatic leiomyosarcoma (PHL).

Methods

Clinical data of 1 patient with PHL who was diagnosed and treated in the First Affiliated Hospital of Xi'an Jiaotong University in October 2017 were analyzed retrospectively. The female patient, aged 49 years, was admitted to our hospital due to "space-occupying lesions of the liver detected by ultrasound examination". A hypoechoic region in the caudate lobe of liver was found by ultrasound examination. Multiple nodule-like and lumpy low-density shadows in the right lobe and caudate lobe were observed by abdominal CT scan. The diagnosis of PHL was confirmed by liver biopsy and immunohistochemical staining. TACE combined with chemotherapy was adopted.

Results

The patient received TACE on December 14, 2017, and was given with 6 cycles of adjuvant chemotherapy (gemcitabine+docetaxel) after TACE. The lesion was found slightly enlarged in the reexamination on April 16, 2019 and the chemotherapy regimen was modified to gemcitabine + albumin-bound paclitaxel for 3 cycles. On May 20, 2020, the reexamination found that the lesion was obviously enlarged. After the secondary TACE, the patient recovered well. As of July 1, 2020, the patient had lived a high quality of life, and no tumor recurrence was found during postoperative follow-up. Clinical data of 15 adult patients with PHL were retrieved from PubMed database between 2000 and 2020. 6 cases were male and 9 female, aged from 25 to 77 years, with a median age of 54 years. The primary symptoms were mainly abdominal pain and discomfort, and the tumors were mainly located in the right lobe. No specific manifestations was observed in laboratory and imaging examination. Pathological examination showed that spindle-shaped tissue cells were arranged in bundles. Immunohistochemical staining found positive results for SMA, desmin and vimentin, whereas negative results for S-100 and cytokeratin in the tissue cells. Surgical resection was performed in 9 cases, chemotherapy in 2, including 1 of surgical resection combined with chemotherapy, liver transplantation in 1, TACE in 2 and conservative treatments in 2, respectively. During 3-82 month follow-up, 2 cases were lost to follow-up, 6 cases died and 7 survived.

Conclusions

PHL is a rare disease. Pathological examination is the only effective approach to confirm the diagnosis. Surgical resection can achieve relatively better clinical efficacy.

图1 一例原发性肝平滑肌肉瘤患者肝脏增强CT图注:a为动脉期,b为静脉期,c为门静脉期;示肝右叶及尾叶见6.7 cm×6.8 cm的实性软组织肿块影,呈快进快出征象(箭头所示)
[1]
Tsuji M, Takenaka R, Kashihara T, et al. Primary hepatic leiomyosarcoma in a patient with hepatitis C virus-related liver cirrhosis[J]. Pathol Int, 2010, 50(1):41-47.
[2]
Fujita H, Kiriyama M, Kawamura T, et al. Primary hepatic leiomyosarcoma in a woman after renal transplantation: report ofa case[J]. Surg Today, 2002, 32(5):446-449.
[3]
Iordanidis F, Hytiroglou P, Drevelegas A, et al. A 25-year-old man with a large hepatic tumor and multiple nodular lesions[J]. Semin Liver Dis, 2002, 22(1):97-102.
[4]
Lee HJ, Lee JL, Choi WH. A case of primary myxoid leiomyosarcoma of the liver[J]. Korean J Intern Med, 2002, 17(4):278-282.
[5]
Tsiatis AC, Atkinson JB, Wright JK, et al. Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature[J]. Ultrastruct Pathol, 2008, 32(1):25-28.
[6]
Liang X, Shi XM, Xie JP, et al. Liver transplantation for primary hepatic leiomyosarcoma: a case report and review of the literatures[J]. Med Oncol, 2010, 27(4):1269-1272.
[7]
Shivathirthan N, Kita J, Iso Y, et al. Primary hepatic leiomyosarcoma: case report and literature review[J]. World J Gastrointest Oncol, 2011, 3(10):148-152.
[8]
Chelimilla H, Badipatla K, Ihimoyan A, et al. A rare occurrence of primary hepatic leiomyosarcoma associated with epstein barr virus infection in an AIDS patient[J]. Case Rep Gastrointest Med, 2013: 691862.
[9]
Lv WF, Han JK, Cheng DL, et al. Imaging features of primary hepatic leiomyosarcoma: a case report and review of literature[J]. Oncol Lett, 2015, 9(5):2256-2260.
[10]
Giakoustidis D, Giakoustidis A, Goulopoulos T, et al. Primary gigantic leiomyosarcoma of the liver treated with portal vein embolization and liver resection[J]. Ann Hepatobiliary Pancreat Surg, 2017, 21(4):228-231.
[11]
Feretis T, Kostakis ID, Damaskos C, et al. Primary hepatic leiomyosarcoma: a case report and review of the literature[J]. Acta Medica, 2018, 61(4):153-157.
[12]
Liu W, Liang W. Primary hepatic leiomyosarcoma presenting asa thick-walled cystic mass resembling a liver abscess: a case report[J]. Medicine, 2018, 97(51):e13861.
[13]
Mitra S, Rathi S, Debi U, et al. Primary hepatic leiomyosarcoma: histopathologist's perspective of a rare case[J]. J Clin Exp Hepatol, 2018, 8(3):321326.
[14]
Zhu KL, Cai XJ. Primary hepatic leiomyosarcoma successfully treated by transcatheter arterial chemoembolization: a case report[J]. World J Clin Cases, 2019, 7(4):525-531.
[15]
Vella S, Cortis K, Pisani D, et al. Case of primary hepatic leiomyosarcoma successfully treated with laparoscopic right hepatectomy[J]. BMJ Case Rep, 2020, 13(2):e233567.
[16]
Weitz J, Klimstra DS, Cymes K, et al. Management of primary liver sarcomas[J]. Cancer, 2007, 109(7):1391-13960.
[17]
Yamaguchi J, Azuma T, Fujioka H, et al. Leiomyosarcoma occurring in the ligamentum teres of the liver: a case report and a review of seven reported cases[J]. Hepatogastroenterology, 1996, 43(10):1051-1056.
[18]
Pinson CW, Lopez RR, Ivancev K, et al. Resection of primary hepatic malignant fibrous histiocytoma, fibrosarcoma, and leiomyosarcoma[J]. South Med J, 1994, 87(3):384-391.
[19]
Iida T, Maeda T, Amari Y, et al. Primary hepatic leiomyosarcoma ina patient with autosomal dominant polycystic kidney disease[J]. CEN Case Rep, 2017, 6(1):74-78.
[20]
马学真. 软组织肉瘤的诊断和治疗[C]//山东抗癌协会肿瘤化疗分会. 山东省第七届肿瘤化疗会议暨首届"CSCO-山东"肿瘤论坛论文集, 山东潍坊, 2008.
[21]
Husted TL, Neff G, Thomas MJ, et al. Liver transplantation for primary or metastatic sarcoma to the liver[J]. Am J Transplant, 2006, 6(2):392-397.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?